📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Metabolic Phenotyping Predicts Gemcitabine and Cisplatin Chemosensitivity in Patients With Cholangiocarcinoma (2022)

First Author: Manida Suksawat

Attributed to: Impact of an Enterobacteriaceae-rich microbial community on gut health funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.60692/d63x3-5nt82

Publication URI: https://gresis.osc.int//doi/10.60692/d63x3-5nt82

Type: Other